Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹241 Cr₹336 Cr₹279 Cr₹231 Cr₹46 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹241 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹241 Cr
Mar2024₹336 Cr
Mar2023₹279 Cr
Mar2022₹231 Cr
Mar2021₹46 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹241 Cr
-28.28
Mar2024 ₹336 Cr
20.42
Mar2023 ₹279 Cr
20.77
Mar2022 ₹231 Cr
406.94
Mar2021 ₹46 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹134.6 Cr 3.4% 5.5% -50.1% Stock Analytics
ADANI ENTERPRISES ₹411,058.0 Cr -4.6% -0.1% 20.3% Stock Analytics
PREMIER ENERGIES ₹47,192.8 Cr -0.9% -1% -3.7% Stock Analytics
AEGIS LOGISTICS ₹45,361.5 Cr -1.7% 13.3% 82.3% Stock Analytics
ADITYA INFOTECH ₹41,881.1 Cr 1.8% -0.1% NA Stock Analytics
REDINGTON ₹21,756.8 Cr 3.1% -2.8% -16.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

3.4%

5.5%

-50.1%

SENSEX

-1.1%

-0.2%

-6.6%


You may also like the below Video Courses